Semaglutide and Aging: What the 2024 Rat Study Reveals About Possible Anti-Aging Effects
Researchers are exploring whether semaglutide, the popular GLP-1 drug for diabetes and weight loss, might influence aging processes at the cellular level. A 2024 rat study published in Nature Aging offers intriguing clues about how this medication could affect cellular senescence and inflammation beyond its known metabolic benefits.